M. Ryan Collins, CEO
Mr. Collins is one of the co-founders of Edenbridge Pharmaceuticals and currently serves as CEO. Mr. Collins was previously the Vice-President of Finance for DAVA Pharmaceuticals from 2005 until 2008. Prior to joining DAVA, Mr. Collins served as the Assistant Controller for Anda, Inc., the distribution division of Andrx Pharmaceuticals, and also previously served as a valuation consultant for Arthur Andersen LLP. Mr. Collins is a certified public accountant and holds a Master's degree in Business Administration from the University of Florida.
Patrick Chu, President
Mr. Chu is one of the co-founders of Edenbridge Pharmaceuticals and currently serves as President. Mr. Chu was previously the Director of Business Development and Associate General Counsel for DAVA Pharmaceuticals from 2005 until 2008. Prior to joining DAVA, Mr. Chu worked at Wyeth and was also previously an associate at the law firm of Skadden Arps. Mr. Chu holds a law degree from Harvard Law School.
Robert O'Connor, Ph.D., CSO
Dr. O'Connor serves as Chief Scientific Officer for Edenbridge Pharmaceuticals and is responsible for all product formulation, manufacturing and operations. Prior to joining Edenbridge, Dr. O'Connor was Vice President, Product Development & Technical Services, at Norwich Pharmaceuticals. Dr. O'Connor was also previously World Wide Vice President, Technical Operations, for Cordis, a Johnson and Johnson Company. Dr. O'Connor received his Ph.D. in pharmaceutics from the University of the Sciences in Philadelphia (Philadelphia College of Pharmacy & Science) where he currently serves on the Board of Visitors for the College of Graduate Studies.